REZŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active Men
Status:
Recruiting
Trial end date:
2025-01-01
Target enrollment:
Participant gender:
Summary
The study objective is to compare water vapor thermotherapy with the REZŪM™ System to dual
drug therapy for the treatment of symptomatic benign prostatic hyperplasia refractory to
alpha-blocker monotherapy in sexually active men.